Topical Drug Delivery Market- Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By, Product (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products) By Route of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Nasal Drug Delivery) By End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others) By Region and Competition. 2018-2028

Global topical drug delivery market is expected to show an impressive in the forecast period, on the account of high prevalence of skin diseases and burn injuries.  The advantage of the topical drugs that they penetrate deep in the body, although they are applied epidermally on various cases, along with the non-invasive nature of the topical drugs that make it so preferable by the patients and are some of the major factors that are anticipated to boost the global topical drug delivery market in the forecast period.

According to the WHO statistics, burns are a global health issue, accounting for approximately 18,000 deaths annually, majority of these deaths occur in low- & middle-income countries. Topical drug administration includes dermal, ophthalmic, rectal, and nasal administrations. Global topical drug delivery market involves the drug delivery systems of all these sectors. The topical drug delivery is highly suitable for the self-administrations thereby increasing the demand of the drugs, which in turn is responsible for the anticipated growth of the global topical drug delivery market, in the forecast period, 2024-2028. Furthermore, target diseases like diabetes, rising prevalence of vitamins and supplements requirement, along with surge in demand of medicinal cosmetics is supporting the growth of the global topical drug delivery market in the upcoming years.

Increasing Cases of Skin Diseases
The prevalence of skin diseases is on the rise, with an estimated 1 in 3 people worldwide affected by some form of skin disease. This increase in prevalence has led to an increased demand for topical drugs to treat these conditions. Among the most common skin diseases is acne, which affects people of all ages. Other common skin conditions include eczema, psoriasis, and rosacea. These conditions can be caused by a variety of factors, including genetics, diet, stress, and exposure to irritants. The topical drug formulations can  include creams, ointments, gels, and foams, and may contain a variety of active ingredients, such as corticosteroids, antibiotics, or retinoids. According to the Disease Project of Global Burden, several skin diseases like vitiligo, eczema, psoriasis, and skin cancer continue to be the major and leading cause of nonfatal disease burden across the globe and thus further infect a large proportion of the global population. Additionally, according to WHO estimates, around 2-3 million case of non-melanoma skin cancer and approximately 0.1 million cases of melanoma skin cancer are diagnosed every year around the globe. Psoriasis is a widely spread cutaneous disorder around the world and ranges from 0.1% to 11.5%, which is spreading rapidly across the globe with affecting approximately 100 million people around the world. In recent years development and appearance of different nanocarriers used in topical and transdermal delivery systems are in more interest due to their numerous advantages. They have showed overall higher therapeutic efficacy in providing sustained and efficient targeted drug release thanks to their distinctive physicochemical features, such as decreased size to a few nanometers. Such molecular changes result in reversible modification of the skin barriers, which improves treatments' capacity to pass through the skin barrier via nanocarriers and reach the deeper layers of the skin. Due to their various benefits, the development and emergence of several nanocarriers employed in topical and transdermal delivery systems have gained huge attention of pharmaceutical scientists and dermatologists. Their distinct physicochemical properties (e.g., reduced size to a few nanometers) have demonstrated their overall superior therapeutic efficacy in providing sustained and effective targeted drug release  Moreover, consistent research and development of the drugs to increase their efficiency and performance is an important factor for the market growth.

Download Free Sample Report

Growing Number of Surgeries & Organ Transplantation
The increasing cases of chronic diseases has led to an increase in surgeries along with Rise in cases for organ failures leading to the growing need for organ transplantation. according to the Health Resources & Services Administration total around 40,000+ transplants were performed in the year 2021, along with 105,800 number of men, women, and children are on the national transplant list, waiting for the right donor for their transplantation. Additionally, according to the National Kidney Foundation, there are currently 121,678 people waiting for organ transplants, such as out of the total organ transplantation requiring patients in US,100,791 await kidney transplants. Topical drugs can be used to reduce the risk of infection in surgical wounds and transplant sites. Topical drugs offer a non-invasive treatment option for skin diseases, which can be particularly beneficial for patients with sensitive skin or those who may not be suitable for more invasive treatments such as oral medications or injections.  Antimicrobial agents such as silver sulfadiazine, povidone-iodine, and mupirocin can be applied directly to the wound or transplant site to prevent bacterial growth. Moreover, Topical drugs can also improve wound healing by promoting tissue regeneration and reducing inflammation. Agents such as growth factors, cytokines, and platelet-derived products can be applied topically to enhance the healing process Alongwith, antimicrobial properties. The topical immunomodulator drugs such as Imiquimod (approved by the FDA)  for the treatment of superficial BCC (Basal cell carcinoma ) and premalignant actinic keratoses (AK) in organ transplant recipients, it is also utilized in case of treatment for most skin carcinomas includes curettage,  electrodessication, excisional removal, radiation, cryosurgery or laser surgery , and are thus high in demand in the market and is thereby with the rising cases of organ transplantation and  is anticipated to bolster the market growth in the forecast period.

Rising Incidence of Burn Injuries
The increasing cases of burn injuries across the globe is leading to an increased demand for topical drugs for effective burn treatment and management. Several topical antimicrobial agents are utilized for curing burns such as an antimicrobial agent named silver sulfadiazine, which is used to treat 2^nd or 3^rd degree burns in patients. Also, despite technical developments, some dermatoses, such as severe atopic dermatitis, have few treatment choices due to biological barriers, associated systemic side effects, and restrictions in product composition, such as drug solubility. The topical drugs such as antibacterial ointments also prevent infection and prepares the wound to heal. According to WHO, 11 million burn injuries of all types occur across the world annually, out of which 180,000 of which are fatal. Additionally, according to the Lancet Public Health, in 2021, burns were among the major causes for disability, and around 8 million and above disability-adjusted life-years (DALYs). Many patients prefer topical drugs over other treatment options, as they are easy to use, have minimal side effects, and can be applied directly to the affected area. Burn injuries can be extremely painful, and the use of topical drugs is often an effective way to manage pain. Topical drugs such as lidocaine, benzocaine, and capsaicin can be applied directly to the affected area to provide localized pain relief. The topical drugs such as antimicrobial ointments are the main treatment for treating non-surgical burn and are thereby high in demand and is thus anticipated to propel the market growth in future. Additionally, medical conditions such as epilepsy, peripheral neuropathy, and physical and cognitive disabilities lead to a risk associated with burns in many conditions.

Recent Developments

• In May 25, the leading global pharmaceutical company named Almirall S.A.  performed its commercial launch of  Wynzora cream (50 µg/g calcipotriol and 0.5 mg/g betamethasone as dipropionate), in Denmark, developed for the topical treatment of mild to moderate plaque psoriasis in adults including scalp. The product was then made available in Germany, Spain, and the United Kingdom, Additionally, Almirall S.A. became the only biopharmaceutical business in Europe to provide psoriasis patients a variety of treatment options that addressed all aspects of the condition, including topicals, oral systemics, and biologics..

Market Segmentation
The global topical drug delivery market is segmented by product, route of administration, end-user, and region. Based on product, the market is further fragmented into semi-solid formulations, liquid formulations, solid formulations, and transdermal products. Based on the route of administration, the market is fragmented into dermal drug delivery, ophthalmic drug delivery, rectal drug delivery and nasal drug delivery. By End-User the market is segmented into hospitals, clinics, home healthcare, diagnostic centers, and others.

Market Players
Johnson & Johnson SA, Nestlé SA, GlaxoSmithKline Plc, Novartis AG, Merck & Co. Inc., Crescita Therapeutics Inc., Cipla Ltd., Taro Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International Inc., Glenmark Pharmaceuticals Ltd. are some of the major leading companies operating in the global topical drug delivery market.

Report Scope:

In this report, global Topical Drug Delivery market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Topical Drug Delivery Market, By Product:
• Semi-Solid Formulations
• Liquid Formulations
• Solid Formulations
• Transdermal Products
• Topical Drug Delivery Market, By Route of Administration:
• Dermal Drug Delivery
• Ophthalmic Drug Delivery
• Rectal Drug Delivery
• Vaginal Drug Delivery
• Nasal Drug Delivery
• Topical Drug Delivery Market, By Distribution Channel:
• Online
• Offline
• Topical Drug Delivery Market, By End User:
• Hospitals
• Clinics
• Home Healthcare
• Diagnostic Centers
• Others
• Topical Drug Delivery Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• South America
• Brazil
• Argentina
• Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global topical drug delivery market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Topical Drug Delivery Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]